Tag: Dr. Jonathan Strosberg

Dr. Jonathan Strosberg to Be Featured Guest for CCF’s Luncheon with the Experts

Jonathan Strosberg, MD, medical oncologist and Section Head of the Neuroendocrine Tumor Division and Chair of the Gastrointestinal Department Research Program at the Moffitt Cancer Center in Tampa, Florida, will be the featured guest for Facebook…

News and Notes from the Carcinoid Cancer Foundation, October 2021

Congratulations to NET expert Pamela Kunz, MD, who was named Woman Oncologist of the Year! Dr. Kunz is Associate Professor of Medicine (Medical Oncology), Director of the Center for Gastrointestinal…

Let’s Talk About NET Survivorship: An Evening for Neuroendocrine Cancer Patients and Caregivers

“Let’s Talk About NET Survivorship!” is a special evening presentation on Friday, June 28 for neuroendocrine cancer patients and caregivers and their health care providers. Attend in person at the Grand Hotel Minneapolis in Minneapolis, Minnesota…

One Step Closer in the US to Peptide Receptor Radionuclide Therapy, PRRT, for Neuroendocrine Cancers

The clock is ticking!! With Advanced Accelerator Applications’ completed New Drug Application (NDA) submission of Lutathera to the U.S. Food and Drug Administration last week, a decision from the FDA is expected by early 2017.  Additionally, an Expanded…

News and Notes for the Carcinoid and Neuroendocrine Tumor Community, March 2016

Breaking News from Advanced Accelerator Applications (AAA) about PRRT Treatment— Advanced Accelerator Applications announced on March 23 that the company has initiated an expanded access program (EAP) in the United States for the investigational…

Neuroendocrine Tumors to Be Focus of Presentations and Posters at ASCO Gastrointestinal Cancers Symposium

Presentations on recent advances in the treatment of neuroendocrine tumors (NETs) and new findings from the NETTER-1 clinical study on PRRT with Lutathera along with posters on a wide variety of subjects about NETs will be part of the program during the…

10 Highlights of the Year 2015 for the Carcinoid and Neuroendocrine Tumor Community

As we begin a new year, the Carcinoid Cancer Foundation looks back on the highlights of 2015 and to a future that we hope will bring greater awareness of carcinoid and neuroendocrine cancers, earlier diagnosis for patients, new treatment options, and …

March 30 Is National Doctors’ Day

March 30 is NATIONAL DOCTORS’ DAY. In recognition of carcinoid/neuroendocrine tumor (NET) doctors – you are our heroes and superheroes!! Pictured are some of the NET specialists throughout the United States.

Pictured by columns, left to right, top …

10 Highlights of the Year 2014 for the Carcinoid and Neuroendocrine Tumor Community

As the Carcinoid Cancer Foundation looks back on the year 2014, we reached out to physicians, patients, support group leaders, listserv managers, patient advocates, and business colleagues to see what they thought were among the highlights of the past…

New OncLive TV Series Focuses on Pancreatic Neuroendocrine Tumors

Pancreatic neuroendocrine tumors, also known as pNETs, form in the hormone-making cells (islet cells) of the pancreas. In this new OncLive TV series, moderator Matthew Kulke, MD, Director of the Program in Neuroendocrine and Carcinoid Tumors at Dana-Farber/Brigham…